Archive: 21/07/2017
COX-2 inhibitors may reverse IDO1-mediated immunosuppression in some cancers
In preclinical studies, tumors that consitutively expressed the protein indoleamine 2,3-dioxygenase (IDO1) responded to the cyclooxygenase-2 (COX-2) inhibitor celecoxib (Celebrex) and had improved infiltration of certain ...
Jul 21, 2017